Predicted Trait | |
Reported Trait | Chronic kidney disease (stage 3 or higher) |
Mapped Trait(s) | chronic kidney disease (EFO_0003884) |
Additional Trait Information | APOL1 risk status |
Score Construction | |
PGS Name | CKD_PRS_AA |
Development Method | |
Name | PRS-CS |
Parameters | phi shrinkage parameter = 1 |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 1,142,436 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000683 |
Citation (link to publication) | Jones AC et al. J Am Soc Nephrol (2024) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 79.6% African: 20.4% 280,722 individuals (100%) |
PGS Evaluation | African: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST008747 Europe PMC: 31451708 |
223,386 individuals | European | MVP, REGARDS |
GWAS Catalog: GCST008747 Europe PMC: 31451708 |
57,336 individuals | African American or Afro-Caribbean | MVP, REGARDS |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM022177 | PSS011829| African Ancestry| 67,819 individuals |
PGP000683 | Jones AC et al. J Am Soc Nephrol (2024) |
Reported Trait: Chronic kidney disease | OR: 1.41 [1.14, 1.76] | AUROC: 0.9 | R²: 0.1 | age, sex, diabetes, PC1-PC10 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011829 | CKD (stage 3 or higher) per KDIGO staging | — | [ ,
37.0 % Male samples |
Mean = [18.0, 99.0] years | African American or Afro-Caribbean (African American) |
— | HYPERGEN | — |